. Providing-hepg2, P. /. Hep3b, and . Prf, HLE, and HLF purchased from ATCC and HuH7 purchased from JCRB (Japanese Collection of Research Bioresources Cell Bank); Prof Institute of Pathology, Cologne, Germany, for FLC-4 and HuH6 cells; and Prof. Scott Friedman, Mount Sinai Hospital, Icahn Medical Institute New York, USA, for LX-2. The authors thankLaboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute) for kindly providing c-myc and TGF? transgenic mice, Thanks to Alexandra Müller (Medical Faculty Mannheim/UMM) and Igor Liebermann (IKP Stuttgart) for technical help. We also thank the interpreter Mrs. S. Namingha for proofreading the manuscript

T. Abbreviations, . Growth-factor, and I. Tgf-?r-i, Transforming growth factor receptor type I, II and III, CM -collagen monolayer, CLD -chronic liver disease, Col1a1 ? Collagen 1a1, CS -collagen sandwich, ELISA ? enzyme?linked immunosorbent assay, HCC -hepatocellular carcinoma, HSC -hepatic stellate cell, CCL 4 ? carbontetrachloride, BDL -bile duct ligation, DEN -diethylnitrosamine, ICC -intrahepatic cholangiocarcinoma, DMEM -Dulbecco?s Modified Eagle Medium, KO -knock out, MDR2 ? multi drug resistance protein 2, phosphatidyl flippase, qPCR -quantitative realtime polymerase chain reaction, SYBR -N?,N?- dimethyl-N-[4-[(E)-(3-methyl-1,3-benzothiazol-2-ylidene) methyl]-1-phenylquinolin-1-ium-2-yl]-N-propylpropane- 1,3-diamine, LX-2 ? human hepatic stellate cell line Lieming Xu-2 HuH7 -human hepatocellular carcinoma cell lines, HuH6 ? human hepatoblastoma cell line

T. Takayama, M. Makuuchi, S. Hirohashi, M. Sakamoto, N. Okazaki et al., Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma, The Lancet, vol.336, issue.8724, pp.1150-1153, 1990.
DOI : 10.1016/0140-6736(90)92768-D

Q. Yu and I. Stamenkovic, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis, Genes Dev, vol.14, pp.163-176, 2000.

S. Daopin, K. Piez, Y. Ogawa, and D. Davies, Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily, Science, vol.257, issue.5068, pp.369-373, 1992.
DOI : 10.1126/science.1631557

H. Marquardt, M. Lioubin, and T. Ikeda, Complete amino acid sequence of human transforming growth factor type beta 2, J Biol Chem, vol.262, pp.12127-12131, 1987.

J. Massague, TGF-?? SIGNAL TRANSDUCTION, Annual Review of Biochemistry, vol.67, issue.1, pp.753-791, 1998.
DOI : 10.1146/annurev.biochem.67.1.753

B. Bierie and H. Moses, Tumour microenvironment: TGF??: the molecular Jekyll and Hyde of cancer, Nature Reviews Cancer, vol.274, issue.7, pp.506-520, 2006.
DOI : 10.1038/nrc1926

J. Wrana, L. Attisano, J. Carcamo, A. Zentella, J. Doody et al., TGF?? signals through a heteromeric protein kinase receptor complex, Cell, vol.71, issue.6, pp.1003-1014, 1992.
DOI : 10.1016/0092-8674(92)90395-S

J. Massague, How cells read TGF-beta signals, Nature Reviews Molecular Cell Biology, vol.1, issue.3, pp.169-178, 2000.
DOI : 10.1038/35043051

S. Cheifetz, J. Weatherbee, M. Tsang, J. Anderson, J. Mole et al., The transforming growth factor-?? system, a complex pattern of cross-reactive ligands and receptors, Cell, vol.48, issue.3, pp.409-415, 1987.
DOI : 10.1016/0092-8674(87)90192-9

S. Cheifetz, H. Hernandez, M. Laiho, P. Tendijke, K. Iwata et al., Distinct Transforming Growth-Factor-Beta (Tgf-Beta) Receptor Subsets as Determinants of Cellular Responsiveness to 3 Tgf-Beta Isoforms, Journal of Biological Chemistry, vol.265, pp.20533-20538, 1990.

L. Ellingsworth, D. Nakayama, J. Dasch, P. Segarini, P. Carrillo et al., Transforming growth factor beta 1 (TGF-?1) receptor expression on resting and mitogen-activated T cells, Journal of Cellular Biochemistry, vol.261, issue.4, pp.489-500, 1989.
DOI : 10.1002/jcb.240390414

P. Segarini, R. Ilm, and S. Seyedin, Binding of Transforming Growth Factor-?? to Cell Surface Proteins Varies with Cell Type, Molecular Endocrinology, vol.3, issue.2, pp.261-272, 1989.
DOI : 10.1210/mend-3-2-261

J. Massague, Receptors for the TGF-?? family, Cell, vol.69, issue.7, pp.1067-1070, 1992.
DOI : 10.1016/0092-8674(92)90627-O

S. Cheifetz, T. Bellon, C. Cales, S. Vera, C. Bernabeu et al., Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells, J Biol Chem, vol.267, pp.19027-19030, 1992.

M. Dickson, J. Martin, F. Cousins, A. Kulkarni, S. Karlsson et al., Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice, Development, vol.121, pp.1845-1854, 1995.

A. Williams, A. Knapton, A. Geiser, J. Letterio, and A. Roberts, The Liver in Transforming Growth Factor-Beta-1 (TGF-??1) Null Mutant Mice, Ultrastructural Pathology, vol.119, issue.5, pp.477-490, 1996.
DOI : 10.3109/01913129609016352

G. Serini and G. Gabbiana, Modulation of alpha-smooth muscle actin expression in fibroblasts by transforming growth factor-beta isoforms: an in vivo and in vitro study, Wound Repair and Regeneration, vol.4, issue.2, pp.278-287, 1996.
DOI : 10.1046/j.1524-475X.1996.40217.x

M. Pinzani and K. Rombouts, Liver fibrosis: from the bench to clinical targets, Digestive and Liver Disease, vol.36, issue.4, pp.231-242, 2004.
DOI : 10.1016/j.dld.2004.01.003

R. Derynck, R. Akhurst, and A. Balmain, TGF-beta signaling in tumor suppression and cancer progression, Nature Genetics, vol.29, issue.2, pp.117-129, 2001.
DOI : 10.1038/ng1001-117

B. Bierie and H. Moses, TGF-?? and cancer, Cytokine & Growth Factor Reviews, vol.17, issue.1-2, pp.29-40, 2006.
DOI : 10.1016/j.cytogfr.2005.09.006

L. Levy and C. Hill, Alterations in components of the TGF-?? superfamily signaling pathways in human cancer, Cytokine & Growth Factor Reviews, vol.17, issue.1-2, pp.41-58, 2006.
DOI : 10.1016/j.cytogfr.2005.09.009

R. De-martin, B. Haendler, R. Hofer-warbinek, H. Gaugitsch, M. Wrann et al., Complementary DNA for human glioblastomaderived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family, EMBO J, vol.6, pp.3673-3677, 1987.

F. Vanky, N. Nagy, C. Hising, K. Sjovall, B. Larson et al., Human ex vivo carcinoma cells produce transforming growth factor ?? and thereby can inhibit lymphocyte functions in vitro, Cancer Immunology, Immunotherapy, vol.43, issue.6, pp.317-323, 1997.
DOI : 10.1007/s002620050339

D. Bissell, S. Wang, W. Jarnagin, and F. Roll, Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation., Journal of Clinical Investigation, vol.96, issue.1, pp.447-455, 1995.
DOI : 10.1172/JCI118055

M. Abou-shady, H. Baer, H. Friess, P. Berberat, A. Zimmermann et al., Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma, The American Journal of Surgery, vol.177, issue.3, pp.209-215, 1999.
DOI : 10.1016/S0002-9610(99)00012-4

K. Matsuzaki, M. Date, F. Furukawa, Y. Tahashi, M. Matsushita et al., Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma, Cancer Res, vol.60, pp.1394-1402, 2000.

C. Coulouarn and C. B. , Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma, Journal of Hepatology, vol.60, issue.6, pp.1306-1309, 2014.
DOI : 10.1016/j.jhep.2014.02.003
URL : https://hal.archives-ouvertes.fr/hal-00952891

C. Coulouarn, C. Cavard, L. Rubbia-brandt, A. Audebourg, F. Dumont et al., Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGF?? signaling pathways, Carcinogenesis, vol.33, issue.9, pp.1791-1796, 2012.
DOI : 10.1093/carcin/bgs208

L. Sulpice, M. Rayar, M. Desille, B. Turlin, A. Fautrel et al., Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma, Hepatology, vol.28, issue.6, pp.1992-2000, 2013.
DOI : 10.1002/hep.26577
URL : https://hal.archives-ouvertes.fr/hal-01068717

D. Bleser, P. Niki, T. Rogiers, V. Geerts, and A. , Transforming growth factor-?? gene expression in normal and fibrotic rat liver, Journal of Hepatology, vol.26, issue.4, pp.886-893, 1997.
DOI : 10.1016/S0168-8278(97)80257-7

K. Lee and T. Liu, Expression of Transforming Growth Factor Betas and Their Signaling Receptors in Stone-containing Intrahepatic Bile Ducts and Cholangiocarcinoma, World Journal of Surgery, vol.27, issue.10, pp.1143-1148, 2003.
DOI : 10.1007/s00268-003-6990-z

H. Shimada, N. Staten, and L. Rajagopalan, TGF-beta1 mediated activation of Rho kinase induces TGF-beta2 and endothelin-1 expression in human hepatic stellate cells

D. Bissell, Primary hepatocyte culture: substratum requirements and production of matrix components, Fed Proc, vol.40, pp.2469-2473, 1981.

S. Roth-eichhorn, K. Kuhl, and A. Gressner, Subcellular localization of (latent) transforming growth factor ?? and the latent TGF-?? binding protein in rat hepatocytes and hepatic stellate cells, Hepatology, vol.73, issue.6, pp.1588-1596, 1998.
DOI : 10.1002/hep.510280619

J. Dzieran, J. Fabian, T. Feng, C. Coulouarn, I. Ilkavets et al., Comparative Analysis of TGF-??/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines, PLoS ONE, vol.50, issue.8, p.72252, 2013.
DOI : 10.1371/journal.pone.0072252.s008
URL : https://hal.archives-ouvertes.fr/hal-01134479

L. Xu, A. Hui, E. Albanis, M. Arthur, O. Byrne et al., Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis, Gut, vol.54, issue.1, pp.142-151, 2005.
DOI : 10.1136/gut.2004.042127

M. Katzenellenbogen, L. Mizrahi, O. Pappo, N. Klopstock, D. Olam et al., Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice, Molecular Cancer Research, vol.5, issue.11, pp.1159-1170, 2007.
DOI : 10.1158/1541-7786.MCR-07-0172

S. Friedman, Mechanisms of Hepatic Fibrogenesis, Gastroenterology, vol.134, issue.6, pp.1655-1669, 2008.
DOI : 10.1053/j.gastro.2008.03.003

G. Michalopoulos, Liver regeneration, Journal of Cellular Physiology, vol.169, issue.2, pp.286-300, 2007.
DOI : 10.1002/jcp.21172

M. Czaja, F. Weiner, K. Flanders, M. Giambrone, R. Wind et al., In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis, The Journal of Cell Biology, vol.108, issue.6, pp.2477-2482, 1989.
DOI : 10.1083/jcb.108.6.2477

N. Thompson, K. Flanders, J. Smith, L. Ellingsworth, A. Roberts et al., Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice, The Journal of Cell Biology, vol.108, issue.2, pp.661-669, 1989.
DOI : 10.1083/jcb.108.2.661

Q. Wang, W. Usinger, B. Nichols, J. Gray, L. Xu et al., Cooperative interaction of CTGF and TGF-?? in animal models of fibrotic disease, Fibrogenesis & Tissue Repair, vol.4, issue.1, p.4, 2011.
DOI : 10.1186/1755-1536-4-4

T. Shirasaki, M. Honda, T. Shimakami, K. Murai, T. Shiomoto et al., Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway, Hepatology, vol.3, issue.5, pp.1519-1530, 2014.
DOI : 10.1002/hep.27277

B. Wang, P. Koh, C. Winbanks, M. Coughlan, A. Mcclelland et al., miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-??2 Expression, Diabetes, vol.60, issue.1, pp.280-287, 2011.
DOI : 10.2337/db10-0892

S. Biressi, E. Miyabara, S. Gopinath, P. Carlig, and T. Rando, A Wnt-TGFbeta2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice, Sci Transl Med, vol.6, pp.267-176, 2014.

X. Sun, Y. He, T. Ma, C. Huang, L. Zhang et al., Participation of miR-200a in TGF-??1-mediated hepatic stellate cell activation, Molecular and Cellular Biochemistry, vol.127, issue.3, pp.11-23, 2014.
DOI : 10.1007/s11010-013-1895-0

D. Tschaharganeh, X. Chen, P. Latzko, M. Malz, M. Gaida et al., Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma, Gastroenterology, vol.144, issue.7, pp.1530-1542, 2013.
DOI : 10.1053/j.gastro.2013.02.009

J. Dong, G. Feldmann, J. Huang, S. Wu, N. Zhang et al., Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals, Cell, vol.130, issue.6, pp.1120-1133, 2007.
DOI : 10.1016/j.cell.2007.07.019

S. Milani, H. Herbst, D. Schuppan, H. Stein, and C. Surrenti, Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease, Am J Pathol, vol.139, pp.1221-1229, 1991.

N. Shackel, P. Mcguinness, C. Abbott, M. Gorrell, and G. Mccaughan, Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression, Gut, vol.49, issue.4, pp.565-576, 2001.
DOI : 10.1136/gut.49.4.565

B. Fan, Y. Malato, D. Calvisi, S. Naqvi, N. Razumilava et al., Cholangiocarcinomas can originate from hepatocytes in mice, Journal of Clinical Investigation, vol.122, issue.8, pp.2911-2915, 2012.
DOI : 10.1172/JCI63212DS1

C. Coulouarn, V. Factor, and S. Thorgeirsson, Transforming growth factor-?? gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer, Hepatology, vol.24, issue.2, pp.2059-2067, 2008.
DOI : 10.1002/hep.22283

P. Bragado, Y. Estrada, F. Parikh, S. Krause, C. Capobianco et al., TGF-??2 dictates disseminated tumour cell fate in target organs through TGF-??-RIII and p38??/?? signalling, Nature Cell Biology, vol.13, issue.11, pp.1351-1361, 2013.
DOI : 10.1101/gad.1061803

T. Feng, . Dj, X. Gu, S. Marhenke, A. Vogel et al., Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma, Clinical Science, vol.60, issue.11, pp.761-774, 2015.
DOI : 10.1186/1471-2407-11-185

S. Oh, E. Kim, D. Kang, M. Kim, J. Kim et al., Transforming growth factor-?? gene silencing using adenovirus expressing TGF-??1 or TGF-??2 shRNA, Cancer Gene Therapy, vol.108, issue.2, pp.94-100, 2013.
DOI : 10.1002/(SICI)1097-0215(19981023)79:5<455::AID-IJC2>3.3.CO;2-K

C. Hellerbrand, B. Stefanovic, F. Giordano, E. Burchardt, and D. Brenner, The role of TGF??1 in initiating hepatic stellate cell activation in vivo, Journal of Hepatology, vol.30, issue.1, pp.77-87, 1999.
DOI : 10.1016/S0168-8278(99)80010-5

S. Hasumura, H. Sujino, S. Nagamori, and H. Kameda, Establishment and characterization of a human hepatocellular carcinoma cell line JHH-4], Hum Cell, vol.1, pp.98-100, 1988.

J. Hengstler, D. Utesch, P. Steinberg, K. Platt, B. Diener et al., CRYOPRESERVED PRIMARY HEPATOCYTES AS A CONSTANTLY AVAILABLE IN VITRO MODEL FOR THE EVALUATION OF HUMAN AND ANIMAL DRUG METABOLISM AND ENZYME INDUCTION*, Drug Metabolism Reviews, vol.7, issue.1, pp.81-118, 2000.
DOI : 10.1021/bp00015a007

E. Wiercinska, L. Wickert, B. Denecke, H. Said, J. Hamzavi et al., Id1 is a critical mediator in TGF-??-induced transdifferentiation of rat hepatic stellate cells, Hepatology, vol.280, issue.3, pp.1032-1041, 2006.
DOI : 10.1002/hep.21135

S. Ghafoory, K. Breitkopf-heinlein, Q. Li, C. Scholl, S. Dooley et al., Zonation of Nitrogen and Glucose Metabolism Gene Expression upon Acute Liver Damage in Mouse, PLoS ONE, vol.19, issue.10, p.78262, 2013.
DOI : 10.1371/journal.pone.0078262.s001

M. Sigal, N. Siebert, D. Zechner, E. Menschikow, K. Abshagen et al., Darbepoetin-?? inhibits the perpetuation of necro-inflammation and delays the progression of cholestatic fibrosis in mice, Laboratory Investigation, vol.7, issue.10, pp.1447-1456, 2010.
DOI : 10.1152/ajprenal.90209.2008

K. Abshagen, M. Brensel, B. Genz, K. Roth, M. Thomas et al., Foxf1 siRNA Delivery to Hepatic Stellate Cells by DBTC Lipoplex Formulations Ameliorates Fibrosis in Livers of Bile Duct Ligated Mice, Current Gene Therapy, vol.15, issue.3, pp.215-227, 2015.
DOI : 10.2174/1566523215666150126114634

E. Pikarsky, R. Porat, I. Stein, R. Abramovitch, S. Amit et al., NF-??B functions as a tumour promoter in inflammation-associated cancer, Nature, vol.2, issue.7007, pp.461-466, 2004.
DOI : 10.1006/scbi.2000.0360

T. Pusterla, J. Nemeth, I. Stein, L. Wiechert, D. Knigin et al., Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice, Hepatology, vol.22, issue.1, pp.363-373, 2013.
DOI : 10.1002/hep.26395

E. Bertran, E. Crosas-molist, P. Sancho, L. Caja, J. Lopez-luque et al., Overactivation of the TGF-?? pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells, Hepatology, vol.17, issue.6, pp.2032-2044, 2013.
DOI : 10.1002/hep.26597

H. Murakami, N. Sanderson, P. Nagy, P. Marino, G. Merlino et al., Transgenic mouse model for www.impactjournals.com/oncotarget synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis, Cancer Res, vol.53, pp.1719-1723, 1993.

J. Haupenthal, V. Bihrer, H. Korkusuz, O. Kollmar, C. Schmithals et al., Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug Levels, Neoplasia, vol.14, issue.5, pp.410-419, 2012.
DOI : 10.1596/neo.111366

K. Livak and T. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-408, 2001.
DOI : 10.1006/meth.2001.1262

S. Spurgeon, R. Jones, and R. Ramakrishnan, High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic Array, PLoS ONE, vol.25, issue.5, p.1662, 2008.
DOI : 10.1371/journal.pone.0001662.s006

C. Meyer, R. Liebe, K. Breitkopf-heinlein, Y. Liu, A. Muller et al., Hepatocyte fate upon TGF-beta challenge is determined by the matrix environment, Differentiation, 2015.

R. Feuer, S. Vlaic, J. Arlt, O. Sawodny, U. Dahmen et al., LEMming: A Linear Error Model to Normalize Parallel Quantitative Real-Time PCR (qPCR) Data as an Alternative to Reference Gene Based Methods, PLOS ONE, vol.20, issue.1, p.135852, 2015.
DOI : 10.1371/journal.pone.0135852.s007

X. Chen, S. Cheung, S. So, S. Fan, C. Barry et al., Gene Expression Patterns in Human Liver Cancers, Molecular Biology of the Cell, vol.13, issue.6, pp.1929-1939, 2002.
DOI : 10.1091/mbc.02-02-0023

C. Guichard, G. Amaddeo, S. Imbeaud, Y. Ladeiro, L. Pelletier et al., Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Nature Genetics, vol.44, issue.6, pp.694-698, 2012.
DOI : 10.1006/meth.2001.1262
URL : https://hal.archives-ouvertes.fr/inserm-00719917

V. Mas, D. Maluf, K. Archer, K. Yanek, X. Kong et al., Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma, Mol Med, vol.15, pp.85-94, 2009.

S. Roessler, H. Jia, A. Budhu, M. Forgues, Q. Ye et al., A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients, Cancer Research, vol.70, issue.24, pp.10202-10212, 2010.
DOI : 10.1158/0008-5472.CAN-10-2607

E. Wurmbach, Y. Chen, G. Khitrov, W. Zhang, S. Roayaie et al., Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma, Hepatology, vol.28, issue.4, pp.938-947, 2007.
DOI : 10.1002/hep.21622

D. Chiang, A. Villanueva, Y. Hoshida, J. Peix, P. Newell et al., Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma, Cancer Research, vol.68, issue.16, pp.6779-6788, 2008.
DOI : 10.1158/0008-5472.CAN-08-0742

K. Archer, V. Mas, K. David, D. Maluf, K. Bornstein et al., Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.11, pp.2929-2932, 2009.
DOI : 10.1158/1055-9965.EPI-09-0767

H. Jia, Q. Ye, L. Qin, A. Budhu, M. Forgues et al., Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma, Clinical Cancer Research, vol.13, issue.4, pp.1133-1139, 2007.
DOI : 10.1158/1078-0432.CCR-06-1025

J. Lee, I. Chu, A. Mikaelyan, D. Calvisi, J. Heo et al., Application of comparative functional genomics to identify best-fit mouse models to study human cancer, Nature Genetics, vol.120, issue.12, pp.1306-1311, 2004.
DOI : 10.1073/pnas.091062498

O. Neumann, M. Kesselmeier, R. Geffers, R. Pellegrino, B. Radlwimmer et al., Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors, Hepatology, vol.31, issue.2, pp.1817-1827, 2012.
DOI : 10.1002/hep.25870

K. Shimokawa, K. Mogushi, S. Shoji, A. Hiraishi, K. Ido et al., iCOD : an integrated clinical omics database based on the systems-pathology view of disease, BMC Genomics, vol.11, issue.Suppl 4, p.19, 2010.
DOI : 10.1186/1471-2164-11-S4-S19

J. Lee, J. Heo, L. Libbrecht, I. Chu, P. Kaposi-novak et al., A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells, Nature Medicine, vol.149, issue.4, pp.410-416, 2006.
DOI : 10.1111/j.1349-7006.2003.tb01366.x